Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathias Streitz

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
BMJ (Clinical Research Ed.)|October 22, 2020
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trialAndy Roemhild, Natalie Maureen Otto, Guido Moll, et al.
JCI Insight|December 7, 2018
A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studiesSabine Ivison, Mehrnoush Malek, Rosa V Garcia, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 10, 2020
Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipientsPaul N Harden, David S Game, Birgit Sawitzki, et al.
Cell|January 15, 2022
Complement activation induces excessive T cell cytotoxicity in severe COVID-19Philipp Georg, Rosario Astaburuaga-García, Lorenzo Bonaguro, et al.
Lancet (London, England)|May 25, 2020
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trialsBirgit Sawitzki, Paul N Harden, Petra Reinke, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
BMJ (Clinical Research Ed.)|October 22, 2020
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trialAndy Roemhild, Natalie Maureen Otto, Guido Moll, et al.
JCI Insight|December 7, 2018
A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studiesSabine Ivison, Mehrnoush Malek, Rosa V Garcia, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 10, 2020
Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipientsPaul N Harden, David S Game, Birgit Sawitzki, et al.
Cell|January 15, 2022
Complement activation induces excessive T cell cytotoxicity in severe COVID-19Philipp Georg, Rosario Astaburuaga-García, Lorenzo Bonaguro, et al.
Lancet (London, England)|May 25, 2020
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trialsBirgit Sawitzki, Paul N Harden, Petra Reinke, et al.
Pageof 5